The syncytiosomes released in vitro by human melanoma cells (Mel888 and Mel624) expressing the GALV-F protein act as a tumor antigen source, activating CD8+ T lymphocytes by crosspresentation of gp100, a melanoma-associated antigen [11, 16]. Here, CD8A is linked to neoplasm.